AI-based Assessment of Risk Factors for Coronary Heart Disease in Patients With Diabetes Mellitus and Construction of a Prediction Model for a Treatment Regimen
Background: This study aimed to construct a prediction model for a treatment plan for patients with coronary artery disease combined with diabetes mellitus using machine learning to efficiently formulate the treatment plan for special patients and improve the prognosis of patients...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-06-01
|
| Series: | Reviews in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/RCM/26/6/10.31083/RCM36293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: This study aimed to construct a prediction model for a treatment plan for patients with coronary artery disease combined with diabetes mellitus using machine learning to efficiently formulate the treatment plan for special patients and improve the prognosis of patients, provide an explanation of the model based on SHapley Additive exPlanation (SHAP), explore the related risk factors, provide a reference for the clinic, and concurrently, to lay the foundation for the establishment of a multicenter prediction model for future treatment plans. Methods: To investigate the relationship between concomitant coronary heart disease (CHD) and diabetes mellitus (DM), this study retrospectively included patients who attended the Beijing Anzhen Hospital of Capital Medical University between 2022 and 2023. The processed data were then input into five different algorithms for model construction. The performance of each model was rigorously evaluated using five specific evaluation indicators. The SHAP algorithm also provided clear explanations and visualizations of the model's predictions. Results: The optimal set of characteristics determined by the least absolute shrinkage and selection operator (LASSO) regression were 15 features of general information, laboratory test results, and echocardiographic findings. The best model identified was the eXtreme Gradient Boost (XGBoost) model. The interpretation of the model based on the SHAP algorithm suggests that the feature in the XGBoost model that has the greatest impact on the prediction of the results is the glycated hemoglobin level. Conclusions: Using machine-learning algorithms, we built a prediction model of a treatment plan for patients with concomitant DM and CHD by integrating patients' information and screened the best feature set containing 15 features, which provides help and strategies to develop the best treatment plan for patients with concomitant DM and CHD. |
|---|---|
| ISSN: | 1530-6550 |